Ariane Lapierre, MD, PhD

Hospices Civils de Lyon

Pierre Benite, Rhône

Disclosures:

Employment: none
Compensation: Astra Zeneca: Honoraria-End Date: 2026 ;Elekta: Honoraria-End Date: 2025 ;Merck: Honoraria, Travel Expenses-End Date: 2026
Ownership: none
Leadership: none

Presentations

Sep 27

105 - Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial

Room 205

03:10pm - 03:20pm ET

Sep 30

105 - Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial

Room 109

08:00am - 08:00am ET